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Trcawnem ef SH-SY5Y human ncusobWonu~ ceils :x-&h Ihe protdn kin= inhibitor stauresporinc. induced be% morphological and functional 
di~~~~ in thcs~ ells The efF&ts of franc wx comyrablc la those induced by tbc protein kinase C (PKC) activator. 12-O 
terradccanoyl pbo&oI I-&azatc tTPAb Gth nspeet to induction o~oeuronal differentiation. i.c. ncuriteautgrowth. inhibition of DNA synthesis, 
induction and dotm-xegulation of c-rn>r protein expression. induction of mRNA for both ncuropcptide Y (NPY) and growth associated protein 
-G tGAW3jand stimulation of t>Iusinc hydrovkw cxpnzssion. Staurospminc railed to tmnslllcate PKC to the mcmbranc fraction or to stimulate 
pbosphcqlation of the endogcnous PKC substrate Jf, 80.800 tpX0). instead. staurosporinc inhibited TPA-induoed phosphorylation of ~80. 
Staurosporincz Pmwin kinasc C: Ncuroblastoma diffcrcnriation: Ncuropeptide Y: Tyrosinc hydroxylasc: GAP-43: Myc 
I. iNTRODU~iON 
SH-SYSY human neuroblastoma cells di&&rcntiate 
to mature neuronal cells when treated with the phorbol 
ester. 11-O-tctradeunoyl phorbol I3-acctatc (TPA) 
(I.?]. The actions of tumcwr promoting phorbol esters 
have been shown to be mediated by protein kinase C 
(PKC) 131. The role of PKC in differentiation of SH- 
SYSY c&is unclear at prwznt. H-7. an inhibitor of the 
cnzymc. failed to block the TPA-induced maturation of 
SH-SYSY cells but instead potentiated ncurite out- 
growth induced by the phorbol ester in these cc& [a]_ 
Down-regulation of PKC, on the other hand. inhibited 
the TPA-induced diffcrcntiation [5j. 
Staurosporinc. a microbial alkaloid. is a potent inhib- 
itor of protein kinases, including PKC [6.7j_ In the pres- 
ent stud:- WC hnvc comp;ircd rhc effects ~fstaurosporine 
with those of TPA on morphological diffcrcntiation. 
induction and down-regulation or c-myc protein. 
stimulation of ncuro~ptidc Y (NPY) and growth-asso- 
ciated protein GAP-431 mRNA expression and induc- 
tion of tyrosinc hydroxylase protein clvpmsion in SH- 
SYSY cells. Effwts of- staurosporine on intracellular 
d~st~bution of PKC as ~$1 as on cndoE~~ous PKC 
substrate jM, 8OBOO ip80) phosphorylation wzre also 
studied. 
2. MATERIALS AND METHODS 
Monoclon~t antibody ?O c-myc protein 19El0) [8] was a kind gift 
from Dr. K. Alitalo (Dept. of Virology and Pathology. Univ. of 
Hulsinki. Finland) and panmyc polyclonal antibody was from 
Cambridge Research Laborator& (Cambridge. UK). The mono- 
clonal antibody against PKC was from Amcnham (UK). The poly- 
cional antibody against tyrosinc hydroxylasc was purshascd from 
~oehrin~er-~~annh~im t~crm~ny). 
SH-SYSY cells [Y] wrc donated by Dr. Juw Bisdlcr (Sloan Kcttcr- 
ing lnstitutc. New York. USA). The ccllr were cultured as previously 
&xrihcd 131. 
Cellsw& sccdcd at a density or’6 I x IO’ per 5 diameter Pctn dish. 
St~uros~~~c ~Kyo\w Hakko. Tokyo. fan~nl or TPA was added 14 
h after plating. DXA syntbcsiu was assayed by inctt~baiin- the c&s in 
the prcwnw oF0.5 #Ciiml of [‘Hjthymidlrlc 1; r Z t;. I ::i: ,dls wc’rc 
washed and counted for radioactivity as dcscribcd in [5]. 
Northern analysis or pofyAt + t RNA ws pcrformcd cxcntially as 
prc%iouJy dcswibcd by randam prime lab&d cDNA probes [S]. The 
cONA Ibr Ihcccding region orhuman liAP-43 U’BS gcncrard by PCR 
&rtofi E.. BCMtolw. C.. P&htman S. and Hammcrting U.. ;a bc 
pubIi~h~). The probes for human NDY [to] and human glywral- 
~ch~~c-~-ph~~p~~te dehydrcpnaw GAPDH I [i I] wxc f?om Drs, 
Dan Lxhammar and Kay Wu. rqwaircty. 
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1% rtprotinin and U. 1 mM phenylmrtyl4phttn~ t fluoride. Nuclsi rscrc 
pclk14 by ~~~tf;fu~iiti~~I~ itt l.tlffo x XI. fr~~ti~~n~(L~ on a 111% SDS 
pelyacrylamidc gels and subscqucnlty and~yxti by a Wcstcm btotling 
method according to a pmrocol by Cambridge Research Laboratorkx 
The analysis of lyfosinc hydroxylasc c*prcssion was pcrfonncd as 
dcscribcd in [I>] by bomo~cni~i~~ thecells in .fOO@ of 50 mM pots- 
sium phosphate buffer. pi-! 7.4. containing 320 mM sucrose. I mM 
EDTA. I mM DTT‘. leupcptin 100 pus/ml and 0.5 mM ph~ny~rn~thyl- 
sulphonyl llucridc. fhc homogcnntc was ccntrifugcd at 10.000 x R for 
10 min and samples from the su~mnt~nt wcrc analyscd by Western 
blolting as described abow using :*nti-rabbit TN antibody (Boch- 
anger-M~nnheim}. 
PKC was isolntcd as prcviowdy dcscribcd [4] and analyscd hy WCSI- 
cm blotting method t%XX&ttiy as described ahove and dctcxztc$ with 
a moncc!on4 an:ibody which rccognizcs the o! andb subtypes ol’PKC. 
Cdls were &wn in’ IO cm diameter p@ri dishes, C’;trricr fret: “1’0, 
\vas nddcxl nI IO0 pCi/ml 4 h prior to harvsst. TI’A ( IO0 nM) and/or 
st~~ilro~porin~( 100 nMf wcrc prcscnt during the linal 60 min crl‘ineuha- 
tion, The cells were washed rapidly with icecold phosphate bull’ircd 
saline and Iysed by addition ef 150~1 bulk. which containd 20 mM 
Tri+HC’l. pH 7.5. 2 mM EDTA. 2 mM EClit. 2%J mM sucrose. 5 
mM dithiuthr~;t~l.~.l mhl phcnylmcthgiauiphun~i tluuride. kupcptin 
50 @mi and OS% Triton X-IO@= The sampks were b&cd and ccn- 
trifugcd at t3.0(!(! x ,q 6x 5 min. AFtcr addition of Lacmmii sampic 
buffer (141 the sampk% were resolved an a 7.5% SE&PAGE and p%@ 
ph~pho~~tjon was rmekd by cxp&ng the dried ge! to an X-ray 
lilm (Amcnham). 
3. RESULTS 
SN-SY5Y cells treated with stuurosp~~nc (25 nM) 
for 72 h exhibited a differentiated ncuronal morphology 
with long, neuritc-like proccsscs (Fig. 16). which were 
not detected in untrcatcd cells (Fig. IA). 
Staurosporinc at 10 and 25 nM aused a total inhibi- 
tion of DNA synthesis in SH-SYSY cells (Fig. IC). At 
both conccntmtions staurosporinc was more effcctivc 
than 10 nM TPA (Fig. IC). which concentration has 
previously been shown to be within the optimal TPA 
concentration range for inhibition of cell growth in 
these cells [15]. 
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mlWA aas m-cd (Fig_ 2Al As ,*n pmiously 
[lqlXii&cd+ni+reasei+heexp=5kmofNPY 
mRNA~$@A~Alsosidsidsidsidsidsidsi ,causcdanin- 
utz@~Ofl’+lPYmRNA@ii2A).Thein- _w;rr*in~wiihbo&agents. 
&vi&s rcsukr ha* shown that the TPA-induced 
neuriteoutgrun&inSHsysYazIkisaccoutpan%!dby 
anincrez& cnprcssian ofGAP mRNA [I7j. Simiir 
multswereaklQobta&edinthisshXlywberebothTPA 
andstaumrsporinecausedasigu&antimrreaseinGAP- 
43 mRNA m The stimulatioa though. was higher 
in TPAated cells compared to azlls which received 
staurosporine (Fii 2B). 
Expmssion oft& h+oxylaseprotein t-60 kDa) 
in untreated SH-SY5Y ceIk was below the detection 
limit of our method {Fig. 2D). A dramatic &easc in 
&& hydroxylase expmssion was seen in ceils treated 
&h 25 nM staurospotine for 72 h (Fig. 2D) while only 
A 
B 
c 
0 
a marginal stimulation in the level this enzyme occurred 
in cells whii received I-PA. 
In SH-SY5Y cell treated with either TPA (IO nM) 
or stauros@ne (UnM) both induction and down- 
reguIation of c-myc protein expression was obsetved as 
ar&sed by Western Matting (Fig. 3). The c-myc mono- 
donal antiiy 9E10 detec&d almost equal Ievels of 
c-m_yc protein in SH-SY5Y cells compared to COLD 
320 cells, which contain an tip&d c-myc gene (181 
(Fig_ 3). The 9EIO antibody reacted only faintly with 
proteins isolated from U-1690 cells containing an 
amplii I_-myc gene [19] (Fig. 3). The myc proteins 
expressed inSH-SYSY cells were additionally examined 
with a poly&maI panmyc antibody directed against he 
highly conserved my&ox portion of the myc family of 
proteins m]. An induction of myc proteins by 30 min 
and a down-regulation by 24 h in the presence of TPA 
or staurosporine was seen with the panmyc antibody 
(Fig. 3). The myc protein detected by the panmyc anti- 
body was of the same size as the c-myc protein (62-64 
kDa) detected by the 9ElO antibody. The expression of 
this myc protein also correIated with the respective 
mRNA levels previously described for c-myc in TPA- 
treated SK-SY5Y cells j213. It is thus concluded that the 
panmyc antibody reacted mainly with the c-myc protein 
in SHSYSY cells, although these cells do express in 
addition to c-myc at least N-myc (211 and L-myc 
mRNA (A. Jalava, unpublished observation). 
In untreated SK-SYSY cells almost all immunoreac- 
tive PKC protein was in the cytosolic fraction (Fig. 4A). 
Incubation of the cells in the presence of 25 nM stauro- 
sporine for up to 24 h had no effi on the intracellular 
distribution of PKC (Fig. 4A). 
Treatment of SK-SYSY cells with 100 nM TPA for 
60 min resuttcd in an incrcascd phosphorylation of the 
~80 substrate (Fig. 48). When both TPA (100 nM) and 
staurnsporinc (100 nM) were added simultaneously a
significant reduction in the p80 phosphorylation was 
observed (Fig. 4B). Sta urosporine (100 nM) alone 
caused a slight decrease in the pEl0 [phosphorylation as 
compared to control (Fig. 48). 
4. DlSCUSSION 
The results from the present study show that stauro- 
sporinc inducts a mature neuronal phenotype in SH- 
SYSY neuroblastoma cells. This is based on several 
findings- Stauroswrine elTcctively inhibited DNA syn- 
thesis and induced outgrowth of long., neurite-like 
processes. This w* accompanied by an increased 
1nRNA lesel of GAP-43, a growth-associated protein 
rp!Xie for rroruzl process [22]. ABhough s*&ur+ 
sporinc was a somewhat wcakcr inducer of GAP43 
mRNA compared to TPA. this result would irrdicatc 
rhat at kaa some of the processes in staurosporinc- 
kar;lRd SM-SY SY cells arc axonat. 
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fig. 3. Expression of myc proteins in TPA- and staurosporine-treated SH-SYSY cells. Nuclei samples from SWZY5Y+ CXX.0 320 and U-1690 
cells were anaiyscd byWcstcrn blotting as described in Materials and Methods. Expression of myc proteins in SH-SYSP‘ c&Is treated with TPA 
or stau~spo~nc (STAU) were analysed by a ~~yclona~ panmyc antibody as indicated in the J&urn. Ia ~n~pa~so~. paraBet samples from COLO 
320, U-1690 and TPA-treated SH-SYSY cells analyscd by a monoclonal antibody to c-myc (9ElOf wcrc also ineludcd as indicated in the figure. 
mented finding in differentiated neurobtastoma cells 
[2X25]. In TPA-treated SH-SYSY cells a dramatic in- 
crease in noradrenaline content LSIS uecn reporteG 11,411. 
In this study both TPA and staurosporine stimulated 
tyrosine hydroxylase protein expression. The increase in 
s~urospu~ne-treated celfs was, however, signi~cantly 
higher compared to the levels of tyrosine hydroxylase 
expressed in TPA-treated cells, Similar increases were 
observed in noradrenaline content in cells treated with 
either TPA or staurosporine. the concentration of nora- 
drenaline trcing significantly higher in staurosporine- 
treated cells (Jalava and Heikkil~~ to be p~blish~). 
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Doun-rqgulakn or c-n&c proto4xIcogcnc csprcs- 
sion has been implicated in in vitm diikwntiarion of 
several ccl1 types [_30-32]_ in the prcscnr study stz1uro- 
sporinc and TP.A modulated axnyc prorcin in 3 si?rilar 
fashion as previously reported for c-my mRNA lcvcls 
in TPA-tteated SH-SWY cells P_l]. 
Ii is; &vious frau the results of this aud>y that if any. 
stauraporine only has inhibitoF clTix~~ on PKC since 
it failed IO stimulate pS0 phosphor&ion or to \ra&- 
catc PKC to the membrane fi-uction. Instead. stauro- 
sporine inhibited blah ihc WA-sWuh:cd and basal 
p80 phusphoryludon. It is ~hcrcforc unlikely that the 
actions ot’~~urospurinc in SH-SY 5Y cells arc mcdiatcd 
thrwugh activation of PKC. 
It is also unlikcls that the eGxts of staurosporine arc 
due to inhibition of PKC. The cnqmc has been shown 
ie bc active in TP.4-wcacd SM-SYSY c&s [17]_ and 
dowwcgula~ion of PKC by bcosratin 1 blocks the 
TPA-induc4 dilrantiation in thcsc ~41s (5) In addi- 
tton induction of ncuritc outgrowth and tyrosinc hy- 
droxylwz cxptession. and inhibition of DNA synthesis 
by staurosporinc xc not afl’iicd by a prcccding down- 
qdation of PKC br bryoswin I (Jalava and HcikkilP. 
to bc publish& 
In conclusion the rcsul~s or this srudy show Ihat dif- 
krcntialion of SH-SI’SY human ncuroblastoma czlts 10 
maw-c noradrcncrgic phcnowp can b, triggcrcd 
through both PKC-dcpcndcnt and -indcpcndcnt prrlh- 
\\3y. 
REFERENCES 
[q kIma_ AXI- Hciik~Z. J.L AkcrlinrL G, Pcrrit. G.R. and 
hkcrm;m. K-f-0. (19901 Cancer Rcs 50. _U22--3428. 
[6] Tamaoki T, Nomotn, H, Takahsshi I.. +&IO. Y.. Morimoto. 
XI. and Tomit& F- (19X6) Eliihcm- Bioph>s RCS. Commun. I35. 
_w7402_ 
[I X&mm_ H.. Kobay.hi E.. Takrhushi I.. T.lmaoki. T.. Kuzuu. 
Y. and llu. H. I 1987) J. Antibiot. 40. 7#6-70% 
[S] Exm. G.I.. Lai!~ CLK.. Rams+ G. and Bishop. J.M. (1985) 
AloL Ccl1 Bioi. 5.361@3616. 
191 Bicdlcr. J, RaRk~Tarlov. S.. Schachncr. M. and Freedman. L.S. 
Il97Xt Cancer Rcs- _W_ 2513-2652. 
[IO] Minth. CD_ Bloom SK.. Folak. J.M. and Dixon. 1-E. (19x4) 
Prw. NatI. ACZWI Sci. US.4 Xl. 457-l-wXl. 
TSP. J.Y..Sun- ?i.-H_ &WT.-H.. Rccsc. K.S. and Wu. R. (19X5) 
Nucleic Acids Rcc 13, 24X5-233’. 
Fwn. GA. and Hancock. D.C. ( 1985) Ccl1 43. 253 261. 
Kobajashi. K.. Kiuchi. K.. lshii. A.- Karw.ia. N.. Kurosawa. Y.. 
Fujita. K. and Nagatsz T. [ 1988) FEBS Le. 23X. 43 11134. 
~wmmli. U.K. f I9701 Nature 277.68tMi85. 
F;lhlran_ S-. Ruusala. A.-l.. Abrahamsson. L.. Udclstad. L. and 
Nilsson. K. (I983 Ccl1 DilTcr. II. 165-170. 
Whhwn. S.. Mcycrson, G.. Lindgrcn. E.. Scha1ling_ M. and 
Johunsson- 1. ~1991) Proc. Natl. And. Sci. WSA (in press). 
Bjclfman. C.. Xlcyrson. G.. Curtwright. CA.. Mcllstriim. K.. 
Hammcrling U. and WhIman, S. (19901 Mol. Cc11 Biol. 10. 36l- 
370. 
Alitalo. K.. Schwab. M.. Lin. C.C.. Varmus, H.E. and Bishop. 
JAI. (19113) Prw. NatL Aard. Sci. USA X0. 1707~171 I.
!%sch. K. (19X7) Oncogme I. 291.-296. 
%bwb. %I. 119Xx) in: Oncopnc Handbook (E.P. RLddy. A.M. 
SkAka :md T. Cm-ran. ~4s.) pp. 3x1 391. Elscvicr. Antstcrdiiml. 
H;nnmcrling. Cl.. Bjclfmtin. C. ;tnd WhIman. S. ( 19X7) Oncogcnc 
2. 73 77. 
Cio.;lin. K.. Sshrqcr. D.J.. Skcnc. J.H.P. and Banker. G. (19KX) 
s;1turc 336. 672 674. 
I’wwi. K.N. (1975) Biol. Rev. 50. l2Y ..265. 
Singh. 1.N.. Sorrcnlincr. G.. Mciurtncy. D.G.. Macsarclli. R. and 
Kanfcr. J.N. (IWH)) J. Ncurcwi. Rn. 25. 376 485. 
Rupni;th. H.T.. R&n. C;,. Pwrll. J.1:.. Kjdcr. T.A.. C‘;wwn. S.. 
I’~~rc!. S. and Iiill. &I‘. I 19X4) C’;utwr Kc\. u. 26OlJ 1007. 
Adrian. T-.1!.. Allen. J.M.. HkhblIl. S.R.. G!I;II&. MA.. Rwor. 
M.S.. Rabwtr G.W.. Crow. T.J.. Tawmoto. K. and Poluk. J.M. 
(19X3) 93turc .Ut6. SX4 5X6. 
Ed\inswn. L.. tflikanson. R.. WI~IL%ICYII. C. and Uddman. K. 
ttYX7) Trends Ptimvol. Sci. X 231 135, 
Scihh. S.P.. O’II;WC. 3l.bl.T.. T(>rIllril. 0. ;“> ’ SCIJ% :lrv. T.& 
(WY) J. Biul. Chum. 32. 664X-6651. 
